Business integration of AmpTec GmbH into the Life Science business of Merck KGaA, Darmstadt, Germany, operating as MilliporeSigma in the US and Canada

Dear valued client,

The purpose of this notice is to inform you of forthcoming changes to the AmpTec GmbH legal entity.

• On April 2^nd, 2024, AmpTec GmbH will cease to exist as a legal entity.
• All business operations relating to all services provided by AmpTec GmbH to you will be seamlessly continued by the governing entity Merck KGaA, Darmstadt, Germany, operating as MilliporeSigma in the US and Canada.

As a client, you will benefit from this development by having a single legal entity for all services related to our mRNA drug substance contract development and manufacturing offering.

Ordering Information

Due to the integration of the AmpTec GmbH business, there will be changes to some of our contact and ordering details.

As of April 2^nd, 2024, we ask you to place any new order with Merck KGaA, Darmstadt, Germany. Accordingly, for orders placed on or after that date, you will receive corresponding invoices from Merck KGaA, Darmstadt, Germany.

Please ensure the following changes which take effect April 2^nd, 2024, are reflected in your systems and information is current for contacts and your chosen method of placing orders.

1. Company Name, Address, and Contact Details
   
   Merck KGaA
   Frankfurter Strasse 250,
   64293 Darmstadt,
   Germany
   
   +49 (0) 6151 72 0
   
   
2. Tax Identification and Company Registration Numbers
   
   For Merck KGaA, Darmstadt, Germany:
   
   Tax number (Steuernummer): 007 225 65905
   VAT number (USt-IdNr): DE811850788
   Company registration number: HRB 6164, local court of Darmstadt
   
   
3. Bank Details
   
   For Merck KGaA, Darmstadt, Germany:
   
   Bank Name: Deutsche Bank
   IBAN: DE15508700050021016105
   BIC: DEUTDEFF508
   
   
4. Contracts
   
   Regardless of the legal entity integration, Merck KGaA, Darmstadt, Germany, will continue to abide by the terms of every written contract or pricing commitment which our representatives have signed or made in writing prior to April 2^nd 2024, and which extend past this date.
   
   
5. Manufacturing and Quality
   
   
   • The manufacturing legal entity will be Merck KGaA, Darmstadt, Germany
   • Product Specifications and Certificates of Analysis will be issued by Merck KGaA, Darmstadt, Germany
   • The company name on the label for Life Science Products will be Merck KGaA, Darmstadt, Germany
   • The contract partner for Quality Agreements will be Merck KGaA, Darmstadt, Germany
      
6. Customer Excellence
   
   Your primary point of contact in our sales organization remains the same. If you have any questions, please contact your Sales Representative.

Data Privacy Notice

As a result of our corporate reorganization, in order for us to continue processing your customer data in support of our contractual relationship, it is necessary that we transfer your customer data from AmpTec GmbH to the governing entity as mentioned above. In compliance with the applicable laws and regulations, we write to inform you about key aspects of the transfer of personal data.

Together with commercial processes, the necessary data will be transferred from AmpTec GmbH to the governing entity as mentioned above. We will only transfer the necessary personal data to make the business transition possible. Such data will include the name, phone number, and email address.  The recipient of personal data will be the governing entity as mentioned above. The recipient will use the personal data for the purpose of fulfilling the contractual relationship.

The legal basis for the data transfer is our legitimate interest in continuing all business operations. If you object to this transfer, you have two weeks from the date of this notice in which to provide us your objection by emailing us at privacy@emdgroup.com. Please review our privacy policy at https://www.sigmaaldrich.com/US/en/life-science/legal/privacy-statement for further information on how your personal data is processed and your privacy rights.

Kind Regards